| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |